[ij] [ij] [ij] 
Email id

Research Journal of Pharmacy and Technology
Year : 2020, Volume : 13, Issue : 8
First page : ( 4015) Last page : ( 4022)
Print ISSN : 0974-3618. Online ISSN : 0974-360X.
Article DOI : 10.5958/0974-360X.2020.00710.6

Pharmacology for preconditioning in clinical studies

Basati Gholam1, Sepahvand Hamed2, Ghanadi Pardis3, Abbaszadeh Saber4,5, Sedighi Mehrnoosh6,*

1Biotechnology and Medicinal Plants Research Center, Ilam University of Medical Sciences, Ilam, Iran

2Master of Science (MSc) in Surgery/Internal, Emergency Department Nurse, Khorramabad University of Lorestan, Iran

3Medical Student, Lorestan University of Medical Sciences, Khorramabad, Iran

4Department of Biochemistry, Lorestan University of Medical Sciences, Khorramabad, Iran

5Student Research Committee, Lorestan University of Medical Sciences, Khorramabad, Iran

6Cardiovascular Research Center, Shahid Rahimi Hospital, Lorestan University of Medical Sciences, Khoramabad, Iran

*Corresponding Author E-mail: M.Sedighi63@ymail.com

Online published on 16 September, 2020.


The main purpose of this study was to review and introduce the physical and pharmacological stimuli and their potential effects with respect to the pharmacological impacts of preconditioning (PC) in cardiovascular and ischemia clinical studies. In this review, data were retrieved from the Information Sciences Institute, PubMed, Scientific Information Database, and Scopus databases, with a further emphasis on the articles published in the last 10 years. Key words used for this purpose included ischemia, reperfusion, heart, infarction, and preconditioning. The eligible and relevant clinical trials on pharmacological stimuli were included in this review. The relevant articles, all have been published from 1983 - 2016. Today, many studies are being performed to implement and apply PC in clinical human cases, in order to minimize the ischemia reperfusion (IR)-induced complication in certain conditions such as myocardial infarction and heart surgery. The Drugs used in the studies are mostly common agents such as nitroglycerin, oxygen, adenosine, etc., and are among commonly used drugs in cardiovascular diseases, which often increase tissue resistance, and conveniently used in the patient's bedside and are accepted by the patients. Using a physical or pharmacological stimulus before prolonged ischemia increases tissue resistance by activating intracellular mechanisms, thereby reducing the IR-induced, cardiac damage and erythema.



Heart, Ischemia, Reperfusion, Preconditioning, Pharmacology.


║ Site map ║ Privacy Policy ║ Copyright ║ Terms & Conditions ║ Page Rank Tool
777,182,958 visitor(s) since 30th May, 2005.
All rights reserved. Site designed and maintained by DIVA ENTERPRISES PVT. LTD..
Note: Please use Internet Explorer (6.0 or above). Some functionalities may not work in other browsers.